A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand-Reference-Cited by-同舟云学术

A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand

Published:2021-08-13 Issue:33 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Lee Sung Chang¹^ORCID,Ma Jennifer S. Y.¹,Kim Min Soo¹,Laborda Eduardo¹,Choi Sei-Hyun²,Hampton Eric N.¹^ORCID,Yun Hwayoung²^ORCID,Nunez Vanessa¹,Muldong Michelle T.³,Wu Christina N.⁴^ORCID,Ma Wenxue⁴^ORCID,Kulidjian Anna A.⁵,Kane Christopher J.⁴,Klyushnichenko Vadim¹,Woods Ashley K.¹,Joseph Sean B.¹^ORCID,Petrassi Mike¹,Wisler John¹^ORCID,Li Jing¹^ORCID,Jamieson Christina A. M.³^ORCID,Schultz Peter G.¹²^ORCID,Kim Chan Hyuk¹^ORCID,Young Travis S.¹²^ORCID

Affiliation:

1. Department of Biology, Calibr, The Scripps Research Institute, La Jolla, CA 92037, USA.

2. Department of Chemistry and Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

3. Department of Urology, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.

4. Department of Medicine, Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.

5. Department of Orthopedic Surgery, Scripps MD Anderson Cancer Center, La Jolla, CA 92093, USA.

Abstract

CCW702 is a bispecific antibody that combines the specificity of an imaging ligand with the potency of a T cell immunotherapy.

Funder

Wellcome

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference54 articles.

1. Cancer statistics, 2019

2. Nomogram Predicting Prostate Cancer–specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy

3. Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival

4. Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

5. Immunotherapy for prostate cancer: False promises or true hope?

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment;Cancers;2024-01-24

2. A bibliometric and knowledge-map analysis of bispecific antibodies in cancer immunotherapy from 2000 to 2023;Heliyon;2024-01

3. Emerging Immunotherapy Approaches for Treating Prostate Cancer;International Journal of Molecular Sciences;2023-09-20

4. A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer;Biomedicines;2023-07-25

5. Site-Specific Chemical Modification of a Cytokine Mimic for Small Molecule-Based Tumor Targeting;Bioconjugate Chemistry;2023-07-18